Sign Up to like & get
recommendations!
0
Published in 2020 at "Biotechnology and Bioengineering"
DOI: 10.1002/bit.27468
Abstract: Adoptive T‐cell therapy (ACT) has emerged as a promising new way to treat systemic cancers such as acute lymphoblastic leukemia. However, the robustness and reproducibility of the manufacturing process remains a challenge. Here, a single‐use…
read more here.
Keywords:
cell therapy;
bioprocess considerations;
differentiation;
dissolved oxygen ... See more keywords